Scientists from GlaxoSmithKline are to study how traditional Chinese medicine can be applied to modern drugs as part of a revamp of the company’s research and development. Britain’s biggest drug maker last week unveiled the outcome of a review of its 38 groups of scientists, known as Discovery Performance Units (DPU), saying it would close three units and open four. The Sunday Telegraph can reveal the new units will look at traditional Chinese medicines, investigating how their principles can be applied to making new, synthetic, molecules.
